Bitwise Introduces Aptos Staking ETP in Europe

Bitwise Asset Management has launched the first-ever Aptos Staking Exchange Traded Product (ETP), which is set to begin trading on the SIX Swiss Exchange on November 19, 2024. This breakthrough product will allow participants to reap rewards from staking while investing in the Aptos blockchain ecosystem.

How Will the Aptos Staking ETP Benefit Investors?

The Aptos Staking ETP is designed for both institutional and retail investors. Backed by a strong custody framework and independent management, it is expected to generate a net return of around 4.7% from staking APT assets. Earnings will be reinvested within the ETP, providing a consistent return stream. Bitwise seeks to present a secure and regulated avenue for exploring cryptocurrency investments.

What Makes Aptos Stand Out in the Market?

Aptos, a high-performance blockchain launched in 2022, has quickly gained traction, boasting over 8 million active users each month. The development team, consisting of veterans from Meta’s blockchain initiative, has received backing from prominent firms like Andreessen Horowitz and PayPal Ventures.

– The Aptos Staking ETP provides a regulated investment option.
– Investors can expect a net return of about 4.7%.
– Staking rewards create a revenue model akin to stock dividends.
– The launch caters to both individual and institutional markets.
– Aptos has grown to over 8 million monthly users, showcasing its popularity.

Bitwise’s launch of the Aptos Staking ETP represents a significant milestone, facilitating regulated investments in the cryptocurrency space. The product aims to simplify engagement for new developers and users in a secure environment, as noted by Bashar Lazaar from the Aptos Foundation.

You can follow our news on Telegram, Twitter ( X ) and Coinmarketcap
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.